** = Publications listed in SCI/SSCI/Pubmed
** Aliwa, B; Horvath, A; Traub, J; Feldbacher, N; Habisch, H; Fauler, G; Madl, T; Stadlbauer, V
Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
J Cachexia Sarcopenia Muscle. 2023; 14(6):2676-2691
Doi: 10.1002/jcsm.13342
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aliwa, B; Horvath, A; Feldbacher, N; Traub, J; Fauler, G; Stadlbauer, V
Altered gut microbiome and stool bile acids in sarcopenia in cirrhosis
J HEPATOL. 2023; 78: S346-S346.
[Poster]
Web of Science
** Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Feldbacher, N; Aliwa, B; Madl, T; Fauler, G; Horvath, A; Stadlbauer, V
Phascolarctobacterium as a predictor for survival in cirrhotic patients
J HEPATOL. 2023; 78: S354-S354.
[Poster]
Web of Science
** Horvath, A; Traub, J; Aliwa, B; Bourgeois, B; Madl, T; Stadlbauer, V
Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis.
NUTRIENTS. 2022; 14(4):
Doi: 10.3390/nu14040748
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aliwa, B; Feldbacher, N; Horvath, A; Traub, J; Madl, T; Fauler, G; Stadlbauer, V
Altered gut microbiome, metabolome and bile acid composition in sarcopenia in liver cirrhosis
J HEPATOL. Abstracts of The International Liver Congress 2022. 2022; 77: S68-S68.-International Liver Congress; JUN 22-26, 2022; London, ENGLAND.
[Oral Communication]
Web of Science
** Haller, R; Aliwa, B; Horvath, A; Stadlbauer, V
Intestinal hyperpermeability in cirrhosis is predictive for survival and associated with distinct microbiome changes
J HEPATOL. Abstracts of The International Liver Congress 2022. 2022; 77: S179-S179.-International Liver Congress; JUN 22-26, 2022; London, ENGLAND.
[Poster]
Web of Science
** Traub, J; Reiss, L; Aliwa, B; Stadlbauer, V
Malnutrition in Patients with Liver Cirrhosis.
NUTRIENTS. 2021; 13(2):
Doi: 10.3390/nu13020540
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG